keyword
https://read.qxmd.com/read/38642855/fasting-duration-impacts-ribosome-protein-6-phosphorylation-in-zebrafish-brain-new-insights-in-aquatic-organisms-welfare
#21
JOURNAL ARTICLE
Maria Raggio, Daniela Giaquinto, Chiara Attanasio, Antonio Palladino, Vincenzo Esposito, Giuseppe Radaelli, Elena De Felice, Paolo de Girolamo, Livia D'Angelo
BACKGROUND: Short- or mid-term fasting, full or partial, triggers metabolic response known to have in turn health effects in an organism. At central level, the metabolic stimulus triggered by fasting is known to be perceived firstly by hypothalamic neurons. In the field of neuroscience, ribosomal protein S6 (S6) phosphorylation is commonly used as a readout of the mammalian target of rapamycin complex 1 signalling activation or as a marker for neuronal activity. The aim of this study is addressed to evaluate whether the phosphorylation of S6 occurs in the central neurons of zebrafish exposed to four (short-term) and seven (mid-term) days of complete fasting...
April 18, 2024: Annals of Anatomy
https://read.qxmd.com/read/38642702/a-new-era-of-antibody-discovery-an-in-depth-review-of-ai-driven-approaches
#22
REVIEW
Jin Cheng, Tianjian Liang, Xiang-Qun Xie, Zhiwei Feng, Li Meng
Given their high affinity and specificity for a range of macromolecules, antibodies are widely used in the treatment of autoimmune diseases, cancers, inflammatory diseases, and Alzheimer's disease (AD). Traditional experimental methods are time-consuming, expensive, and labor-intensive. Recent advances in artificial intelligence (AI) technologies provide complementary methods that can reduce the time and costs required for antibody design by minimizing failures and increasing the success rate of experimental tests...
April 18, 2024: Drug Discovery Today
https://read.qxmd.com/read/38642684/a-highly-efficient-blocking-elisa-based-on-p72-monoclonal-antibody-for-the-detection-of-african-swine-fever-virus-antibodies-and-identification-of-its-linear-b-cell-epitope
#23
JOURNAL ARTICLE
Weldu Tesfagaber, Wan Wang, Lulu Wang, Rui Zhao, Yuanmao Zhu, Fang Li, Encheng Sun, Renqiang Liu, Zhigao Bu, Geng Meng, Dongming Zhao
Due to the absence of effective vaccine and treatment, African swine fever virus (ASFV) control is entirely dependent on accurate and early diagnosis, along with culling of infected pigs. The B646L/p72 is the major capsid protein of ASFV and is an important target for developing a diagnostic assays and vaccines. Herein, we generated a monoclonal antibody (mAb) (designated as 2F11) against the trimeric p72 protein, and a blocking ELISA (bELISA) was established for the detection of both genotype I and II ASFV antibodies...
April 18, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38642265/-1-h-13-c-and-15-n-backbone-and-methyl-group-resonance-assignments-of-ricin-toxin-a-subunit
#24
JOURNAL ARTICLE
Shibani Bhattacharya, Tassadite Dahmane, Michael J Goger, Michael J Rudolph, Nilgun E Tumer
Ricin is a potent plant toxin that targets the eukaryotic ribosome by depurinating an adenine from the sarcin-ricin loop (SRL), a highly conserved stem-loop of the rRNA. As a category-B agent for bioterrorism it is a prime target for therapeutic intervention with antibodies and enzyme blocking inhibitors since no effective therapy exists for ricin. Ricin toxin A subunit (RTA) depurinates the SRL by binding to the P-stalk proteins at a remote site. Stimulation of the N-glycosidase activity of RTA by the P-stalk proteins has been studied extensively by biochemical methods and by X-ray crystallography...
April 20, 2024: Biomolecular NMR Assignments
https://read.qxmd.com/read/38641492/vlps-generated-by-the-fusion-of-rsv-f-or-hmpv-f-glycoprotein-to-hiv-gag-show-improved-immunogenicity-and-neutralizing-response-in-mice
#25
JOURNAL ARTICLE
Benjamin Trinité, Eberhard Durr, Anna Pons-Grífols, Gregory O'Donnell, Carmen Aguilar-Gurrieri, Silveria Rodriguez, Victor Urrea, Ferran Tarrés, Joel Mane, Raquel Ortiz, Carla Rovirosa, Jorge Carrillo, Bonaventura Clotet, Lan Zhang, Julià Blanco
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) vaccines have been long overdue. Structure-based vaccine design created a new momentum in the last decade, and the first RSV vaccines have finally been approved in older adults and pregnant individuals. These vaccines are based on recombinant stabilized pre-fusion F glycoproteins administered as soluble proteins. Multimeric antigenic display could markedly improve immunogenicity and should be evaluated in the next generations of vaccines. Here we tested a new virus like particles-based vaccine platform which utilizes the direct fusion of an immunogen of interest to the structural human immunodeficient virus (HIV) protein Gag to increase its surface density and immunogenicity...
April 18, 2024: Vaccine
https://read.qxmd.com/read/38641227/proteomic-and-cellular-characterization-of-omicron-breakthrough-infections-and-a-third-homologous-or-heterologous-boosting-vaccination-in-a-longitudinal-cohort
#26
JOURNAL ARTICLE
Yi Zhang, Zhangfan Fu, Haocheng Zhang, Ke Lin, Jieyu Song, Jingxin Guo, Qiran Zhang, Guanmin Yuan, Hongyu Wang, Mingxiang Fan, Yuanhan Zhao, Rui Sun, Tiannan Guo, Ning Jiang, Chao Qiu, Wenhong Zhang, Jingwen Ai
BACKGROUND: The understanding of dynamic plasma proteome features in hybrid immunity and breakthrough infection is limited. A deeper understanding of the immune differences between heterologous and homologous immunization could assist in the future establishment of vaccination strategies. METHODS: In this study, 40 participants who received a third dose of either a homologous BBIBP-CorV or a heterologous ZF2001 protein subunit vaccine following two doses of inactivated coronavirus disease 2019 vaccines and 12 patients with BA...
April 17, 2024: Molecular & Cellular Proteomics: MCP
https://read.qxmd.com/read/38641011/lymphocyte-crossmatch-testing-or-donor-hla-dp-and-dq-allele-typing-effectiveness-in-single-cord-blood-transplantation-for-patients-with-anti-hla-antibodies-other-than-against-hla-a-b-c-and-drb1
#27
JOURNAL ARTICLE
Makoto Osada, Hisashi Yamamoto, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Shigeyoshi Makino, Yuki Asano-Mori, Go Yamamoto, Shuichi Taniguchi, Atsushi Wake, Naoyuki Uchida
Anti-human leukocyte antigen (HLA) antibodies other than those against HLA-A, -B, -C, and DRB1 are a risk factor for engraftment delay and failure, especially in cord blood transplantation (CBT) OBJECTIVES: The primary objective of this study was to assess the impact of the presence of anti-HLA antibodies on CBT and to evaluate the utility of lymphocyte crossmatch testing or additional HLA-DP and HLA-DQ typing of CB units in improving transplant outcomes STUDY DESIGN: We retrospectively assessed the engraftment rates and transplant outcomes of 772 patients who underwent their first CBT at our hospital between 2012 and 2021...
April 17, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38640545/designing-a-size-exclusion-based-hapten-and-the-development-of-a-quantitative-and-visual-time-resolved-fluorescence-immunochromatography-assay-strip-for-detecting-dimethomorph-and-flumorph-in-a-group-specific-manner
#28
JOURNAL ARTICLE
Yuxian Zhu, Yongyi Zhang, Daoping Zeng, Haoyu Chen, Yu Wang, Jinyi Yang, Hong Wang, Zhenlin Xu, Yuanming Sun, Yuanxin Tian, Yudong Shen
Based on the size and surface properties of dimethomorph and flumorph, we used a computer simulation-assisted size exclusion hapten design strategy to develop group-specific monoclonal antibodies that can simultaneously recognize dimethomorph and flumorph. For this, we performed quantitative and visual semi-quantitative time-resolved fluorescence immunochromatography (TRFICA) to simultaneously detect dimethomorph and flumorph in potatoes and apples. In potato samples, the visual limit of detection (vLOD) for dimethomorph and flumorph was 4 ng/mL and 8 ng/mL, respectively, whereas the quantitative limit of detection (qLOD) for dimethomorph and flumorph was 0...
April 15, 2024: Food Chemistry
https://read.qxmd.com/read/38640475/investigating-sars-cov-2-incidence-and-morbidity-in-ponce-puerto-rico-protocol-and-baseline-results-from-a-community-cohort-study
#29
JOURNAL ARTICLE
Chelsea G Major, Dania M Rodríguez, Liliana Sánchez-González, Vanessa Rodríguez-Estrada, Tatiana Morales-Ortíz, Carolina Torres, Nicole M Pérez-Rodríguez, Nicole A Medina-Lópes, Neal Alexander, David Mabey, Kyle Ryff, Rafael Tosado-Acevedo, Jorge Muñoz-Jordán, Laura E Adams, Vanessa Rivera-Amill, Melissa Rolfes, Gabriela Paz-Bailey
BACKGROUND: A better understanding of SARS-CoV-2 infection risk among Hispanic and Latino populations and in low-resource settings in the United States is needed to inform control efforts and strategies to improve health equity. Puerto Rico has a high poverty rate and other population characteristics associated with increased vulnerability to COVID-19, and there are limited data to date to determine community incidence. OBJECTIVE: This study describes the protocol and baseline seroprevalence of SARS-CoV-2 in a prospective community-based cohort study (COPA COVID-19 [COCOVID] study) to investigate SARS-CoV-2 infection incidence and morbidity in Ponce, Puerto Rico...
April 19, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38638976/establishment-and-clinical-application-of-the-hla-genotype-database-of-platelet-apheresis-donors-in-suzhou
#30
JOURNAL ARTICLE
Honghong He, Jingjing Huang, Yuanling Zuo, Yihan Wang, Min Jiang, Yiming Jin, Longhai Tang, Mingyuan Wang
The establishment of a platelet-apheresis donor database may provide a feasible solution to improve the efficacy of platelet transfusion in patients with immune platelet transfusion refractoriness (PTR). This study aimed to establish HLA genotype database in Suzhou, to provide HLA-I compatible platelets for PTR patients to ensure the safety and effectiveness of platelet transfusions. We used a polymerase chain reaction sequence-based typing (PCR-SBT) method to establish the database by performing high-resolution HLA-A, -B, and -C genotyping on 900 platelet-apheresis donors...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38638426/a-novel-dual-mechanism-of-action-bispecific-pd-1-il-2v-armed-by-a-%C3%AE-%C3%AE-only-interleukin-2-variant
#31
JOURNAL ARTICLE
Yongji Jiang, Chuyuan Chen, Yuan Liu, Rong Wang, Chuan Feng, Lili Cai, Shuang Chang, Lei Zhao
INTRODUCTION: Interleukin-2 (IL-2) is one of the first cytokines to be discovered as an immune agonist for cancer immunotherapy. Biased IL-2 variants had been discovered to eliminate Treg activation or enhance the tumor specific T cell cytotoxicity. However, all the biased IL-2 variants pose the risk to overstimulate immune response at a low-dose range. Here, we introduce a novel dual-MOA bispecific PD-1-IL-2v molecule with great anti-tumor efficacy in a high dosed manner. METHODS: The novel IL-2 variant was designed by structural truncation and shuffling...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638035/optimizing-the-design-and-geometry-of-t-cell-engaging-bispecific-antibodies-targeting-cea-in-colorectal-cancer
#32
JOURNAL ARTICLE
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Zangger, Frederik Peissert, Stefanie K Pfister, Christian Pellegrino, Sheila Dakhel Plaza, Roberto De Luca, Markus G Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri
Metastatic colorectal cancer (mCRC) remains a leading cause of cancer-related deaths, with a 5-year survival rate of only 15%. T cell engaging bispecific antibodies (TCBs) represent a class of biopharmaceuticals that redirect cytotoxic T cells towards tumor cells, thereby turning immunologically "cold" tumors "hot." The carcinoembryonic antigen (CEA) is an attractive tumor-associated antigen (TAA) that is overexpressed in over 98% of CRC patients. In this study, we report the comparison of four different TCB formats employing the antibodies F4 (targeting human CEA) and 2C11 (targeting mouse CD3ε)...
April 18, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38637043/efficient-evs-separation-and-detection-by-an-alumina-nanochannel-array-membrane-integrated-microfluidic-chip-and-an-antibody-barcode-biochip
#33
JOURNAL ARTICLE
Jiaoyan Qiu, Qindong Guo, Yujin Chu, Chunhua Wang, Hao Xue, Yu Zhang, Hong Liu, Gang Li, Lin Han
BACKGROUND: Small endosome-derived lipid nanovesicles (30-200 nm) are actively secreted by living cells and serve as pivotal biomarkers for early cancer diagnosis. However, the study of extracellular vesicles (EVs) requires isolation and purification from various body fluids. Although traditional EVs isolation and detection technologies are mature, they usually require large amount of sample, consumes long-time, and have relatively low-throughput. How to efficiently isolate, purify and detect these structurally specific EVs from body fluids with high-throughput remains a great challenge in in vitro diagnostics and clinical research...
May 22, 2024: Analytica Chimica Acta
https://read.qxmd.com/read/38636694/an-up-conversion-fluorescence-lateral-flow-immunoassay-for-rapid-detection-of-daratumumab-in-serum-protein-electrophoresis-clinical-samples
#34
JOURNAL ARTICLE
Yajing Liu, Yanru Tao, Priscilla S-W Yeung, Mengyan Lu, Jing Liu, Fang Yu, Run-Zhang Shi, Ruben Yiqi Luo
BACKGROUND: Daratumumab (DARA) is a commonly used monoclonal antibody (mAb) drug for the treatment of multiple myeloma (MM). Its appearance as a visible abnormal band in the γ-region of a serum protein electrophoresis (SPEP) gel may interfere with the SPEP result interpretation. With the advantages of portability and rapid testing capabilities, up-conversion fluorescence lateral-flow immunoassay (LFA) can be an ideal solution to detect DARA interference. METHODS: An up-conversion fluorescence LFA strip was designed and constructed to perform semi-quantitative DARA testing in clinical samples...
April 16, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38636351/reduction-of-the-hepatic-radioactivity-levels-of-111-in-in-dota-labeled-antibodies-via-cleavage-of-a-linkage-metabolized-in-lysosomes
#35
JOURNAL ARTICLE
Hiroyuki Suzuki, Masato Matsukawa, Rikako Madokoro, Yui Terasaka, Kento Kannaka, Tomoya Uehara
INTRODUCTION: Radiolabeled antibodies are promising tools for cancer diagnosis using nuclear medicine. A DOTA-chelating system is useful for preparing immuno-positron emission tomography and immuno-single-photon emission computed tomography probes with various radiometals. Radiolabeled antibodies are generally metabolized in the reticuloendothelial system, producing radiometabolites after proteolysis in hepatic lysosomes. Because of the bulkiness and extremely high hydrophilicity of DOTA, radiometabolites containing a radiometal-DOTA complex typically exhibit high and persistent localization in hepatic lysosomes...
April 8, 2024: Nuclear Medicine and Biology
https://read.qxmd.com/read/38636292/the-efficacy-of-sacituzumab-govitecan-and-trastuzumab-deruxtecan-on-stable-and-active-brain-metastases-in-metastatic-breast-cancer-patients-a-multicenter-real-world-analysis
#36
JOURNAL ARTICLE
D Dannehl, D Jakob, F Mergel, A Estler, T Engler, L Volmer, M-L Frevert, S Matovina, A Englisch, C M Tegeler, A Rohner, A Seller, M Hahn, K Pfister, A Fink, I Popp, S Lorenz, G Tabatabai, I Juhasz-Böss, W Janni, S Brucker, F-A Taran, A Hartkopf, H Schäffler
BACKGROUND: Fifteen to thirty percent of all patients with metastatic breast cancer (MBC) develop brain metastases (BCBMs). Recently, the antibody-drug conjugates (ADCs) sacituzumab govitecan (SG) and trastuzumab deruxtecan (T-DXd) have shown to be highly effective in the treatment of MBC. However, there are only limited data whether these macromolecules are also effective in patients with BCBMs. We therefore aimed to examine the efficacy of SG and T-DXd in patients with stable and active BCBMs in a multicenter real-world analysis...
April 17, 2024: ESMO Open
https://read.qxmd.com/read/38636175/loop-p-de-of-viral-capsid-protein-is-involved-in-immune-escape-of-the-emerging-novel-variant-infectious-bursal-disease-virus
#37
JOURNAL ARTICLE
Guodong Wang, Nan Jiang, Hangbo Yu, Xinxin Niu, Mengmeng Huang, Yulong Zhang, Wenying Zhang, Jinze Han, Mengmeng Xu, Runhang Liu, Ziwen Wu, Jingzhe Han, Suyan Wang, Li Gao, Hongyu Cui, Yanping Zhang, Yuntong Chen, Yulong Gao, Xiaole Qi
Infectious bursa disease (IBD) is an acute, highly contactable, lethal, immunosuppressive infectious disease caused by the Infectious bursa disease virus (IBDV). Currently, the emerged novel variant IBDV (nVarIBDV) and the sustainedly prevalent very virulent IBDV (vvIBDV) are the two most prevalent strains of IBDV in China. The antigenic properties of the two prevalent strains differed significantly, which led to the escape of nVarIBDV from the immune protection provided by the existing vvIBDV vaccine. However, the molecular basis of the nVarIBDV immune escape remains unclear...
April 15, 2024: Veterinary Microbiology
https://read.qxmd.com/read/38635725/mrna-vaccines-encoding-influenza-virus-hemagglutinin-ha-elicits-immunity-in-mice-from-influenza-a-virus-challenge
#38
JOURNAL ARTICLE
Z Beau Reneer, Harrison C Bergeron, Stephen Reynolds, Elena Thornhill-Wadolowski, Lan Feng, Marcin Bugno, Agnieszka D Truax, Ralph A Tripp
Influenza viruses cause epidemics and can cause pandemics with substantial morbidity with some mortality every year. Seasonal influenza vaccines have incomplete effectiveness and elicit a narrow antibody response that often does not protect against mutations occurring in influenza viruses. Thus, various vaccine approaches have been investigated to improve safety and efficacy. Here, we evaluate an mRNA influenza vaccine encoding hemagglutinin (HA) proteins in a BALB/c mouse model. The results show that mRNA vaccination elicits neutralizing and serum antibodies to each influenza virus strain contained in the current quadrivalent vaccine that is designed to protect against four different influenza viruses including two influenza A viruses (IAV) and two influenza B (IBV), as well as several antigenically distinct influenza virus strains in both hemagglutination inhibition assay (HAI) and virus neutralization assays...
2024: PloS One
https://read.qxmd.com/read/38635656/design-development-and-validation-of-multi-epitope-proteins-for-serological-diagnosis-of-zika-virus-infections-and-discrimination-from-dengue-virus-seropositivity
#39
JOURNAL ARTICLE
Samille Henriques Pereira, Mateus Sá Magalhães Serafim, Thaís de Fátima Silva Moraes, Nathalia Zini, Jônatas Santos Abrahão, Maurício Lacerda Nogueira, Jordana Grazziela Alves Coelho Dos Reis, Flávia Fonseca Bagno, Flávio Guimarães da Fonseca
Zika virus (ZIKV), an arbovirus from the Flaviviridae family, is the causative agent of Zika fever, a mild and frequent oligosymptomatic disease in humans. Nonetheless, on rare occasions, ZIKV infection can be associated with Guillain-Barré Syndrome (GBS), and severe congenital complications, such as microcephaly. The oligosymptomatic disease, however, presents symptoms that are quite similar to those observed in infections caused by other frequent co-circulating arboviruses, including dengue virus (DENV)...
April 2024: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38634995/protocol-for-testing-the-effects-of-ssdna-aptamer-in-hela-and-mcf-7
#40
JOURNAL ARTICLE
Haregewoin Bezu Woldekidan, Zandile Nxumalo, Mutsa M Takundwa, Adugna Abdi Woldesemayat, Deepak B Thimiri Govinda Raj
Conventional approaches for treating tumors encompass chemotherapy, radiotherapy, and surgery. However, these methods come with their limitations when applied in clinical practice. Aptamers are often referred to as "chemical antibodies" and consist of short DNA or RNA molecules, designed to bind to a wide range of targets, including proteins or nucleic acid structures. They exhibit strong affinities and remarkable specificity for their target molecules, making them capable of functioning as therapeutic agents to directly impede tumor cell proliferation...
April 19, 2024: Methods in Molecular Biology
keyword
keyword
67576
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.